Enrichment, Training, and Outreach in the Stanford DRC Stanford University and School of Medicine are renowned leaders in education, scientific innovation, patient care and entrepreneurship. A central aspect of the Stanford Diabetes Research Center (SDRC) Enrichment, Training, and Outreach Program is to leverage these strengths to enhance diabetes research and training. The goals of the SDRC Enrichment, Training and Outreach Program (ETOP) are: 1) To advance diabetes research by serving as the organizing nexus of enrichment activities to foster interdisciplinary education, idea sharing and collaboration; 2) To attract, support and train future diabetes research leaders who will advance diabetes-related knowledge and improve patient care; 3) To facilitate and support the numerous local and national community outreach programs that Stanford has established to improve patient awareness, empowerment and advocacy. The SDRC enhances the environment for diabetes research and training at Stanford through multiple efforts including the establishment of diabetes-research affinity groups to facilitate knowledge-sharing and collaboration, a monthly diabetes research-in-progress seminar series, multiple lecture series for invited speakers, an annual Diabetes Research Day Symposium that showcases new and evolving ideas in the field, a spectrum of training grant opportunities including NIH T32 training programs and numerous patient-oriented events that occur on campus as well as within the community.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
1P30DK116074-01
Application #
9442595
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
1
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Tikkanen, Emmi; Gustafsson, Stefan; Amar, David et al. (2018) Biological Insights Into Muscular Strength: Genetic Findings in the UK Biobank. Sci Rep 8:6451
Tikkanen, Emmi; Gustafsson, Stefan; Ingelsson, Erik (2018) Associations of Fitness, Physical Activity, Strength, and Genetic Risk With Cardiovascular Disease: Longitudinal Analyses in the UK Biobank Study. Circulation 137:2583-2591
Arda, H Efsun; Tsai, Jennifer; Rosli, Yenny R et al. (2018) A Chromatin Basis for Cell Lineage and Disease Risk in the Human Pancreas. Cell Syst 7:310-322.e4
Deng, Bing; Shen, Wen-Jun; Dong, Dachuan et al. (2018) Plasma membrane cholesterol trafficking in steroidogenesis. FASEB J :fj201800697RRR
Singh, Madhurima; Bittner, Stefanie; Li, Yihang et al. (2018) Anti-hyperlipidaemic effects of synthetic analogues of nordihydroguaiaretic acid in dyslipidaemic rats. Br J Pharmacol :
DeSalvo, Daniel J; Miller, Kellee M; Hermann, Julia M et al. (2018) Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative. Pediatr Diabetes 19:1271-1275
Poon, Anna K; Meyer, Michelle L; Reaven, Gerald et al. (2018) Short-Term Repeatability of Insulin Resistance Indexes in Older Adults: The Atherosclerosis Risk in Communities Study. J Clin Endocrinol Metab 103:2175-2181
Ingelsson, Erik; McCarthy, Mark I (2018) Human Genetics of Obesity and Type 2 Diabetes Mellitus: Past, Present, and Future. Circ Genom Precis Med 11:e002090
Peiris, Heshan; Park, Sangbin; Louis, Shreya et al. (2018) Discovering human diabetes-risk gene function with genetics and physiological assays. Nat Commun 9:3855
Singh, Amar Bahadur; Dong, Bin; Kraemer, Fredric B et al. (2018) Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice. Arterioscler Thromb Vasc Biol 38:2448-2459

Showing the most recent 10 out of 46 publications